Consultation Paper No. 10 of 2026 - Proposed Amendments to ADGM’s Cell Companies Framework

Open17 Nov, 2026, 09:00 - 10 Dec, 2026, 23:59

Why are we issuing this paper?

The Abu Dhabi Global Market (“ADGM”) Registration Authority (the “Registrar”) has issued this Consultation Paper to invite public feedback on proposed amendments to the Companies Regulations 2020 (the “Companies Regulations”) and the proposed Companies Regulations (Cell Companies) Rules 2026 (the “Cell Companies Rules”). 

The proposed amendments respond to the increasing use of protected cell companies (“PCCs”) and incorporated cell companies (“ICCs”) in ADGM. They are intended to improve the accessibility, clarity and usability of the framework by retaining substantive legal rights, liabilities and protections in Part 36 of the Companies Regulations, while relocating operational and administrative provisions into standalone rules. 

The proposals are also intended to ensure that ADGM’s cell company framework remains commercially practical and competitive for investors and businesses seeking to establish cell company structures, while retaining the substantive legal protections applicable to members, creditors and other third parties. 

This Consultation Paper summarises the key proposed aspects of the amendments. The summaries provided should be read as an introduction to the amendments only – The precise details and specifics are contained in the annexes and appendices hereto. 

Unless context requires otherwise, terms capitalised in this Consultation Paper should be taken to have the same meanings ascribed to them in the Companies Regulations.

Who should read this paper?

The proposals will be of interest to existing and prospective PCCs and ICCs, their cells, members and professional advisers, as well as fund, insurance, asset-holding and family office structures that use or may use cell companies. We also welcome feedback from other stakeholders, whether based in ADGM or beyond.

How to provide comments

Comments must be submitted through RA’s Consultation Portal at https://raconsultations.adgm.com/. To submit feedback, individuals and entities are required to register for an account on the portal, which is one-time process.

Please note that comments submitted to ra.consultation@adgm.com may not be considered. The email address ra.consultation@adgm.com should only be used for portal-related issues, such as registration, account access, and technical difficulties.

What happens next?

The deadline for providing comments on this proposal is 10 December 2026. 

Following receipt and review of any comments, consideration will be given to whether any modifications to the proposed amendments are required, and the ADGM Board of Directors (“Board”) and the Registrar will then proceed to enact the proposals in their final form. 

You should not act on the proposed amendments until such time as the final amendments to the Companies Regulations and the final Cell Companies Rules and any related guidance are issued on the ADGM website.

 

*Proposed legislations can be accessed under “Materials” tab located on the right-hand side of this Consultation Paper.

**To receive notification of future public consultations published by ADGM Registration Authority, please click “Subscribe” button.

File is downloading...

Submissions

Questions

Q1. DO YOU HAVE ANY CONCERNS WITH OR FEEDBACK ON THE PROPOSED RESTRUCTURING OF PART 36 OF THE COMPANIES REGULATIONS AND THE PROPOSED CELL COMPANIES RULES? ARE ANY PROVISIONS BETTER RETAINED IN PART 36?
Q2. DO YOU HAVE ANY CONCERNS WITH OR FEEDBACK ON THE PROPOSED REGISTERED OFFICE ARRANGEMENTS FOR INCORPORATED CELL COMPANIES?
Q3. DO YOU HAVE ANY CONCERNS WITH OR FEEDBACK ON THE PROPOSED REQUIREMENTS FOR REGISTERS CONFIRMATION STATEMENTS ACCOUNTING RECORDS AND ACCOUNTS BEING CONTAINED IN THE RULES?
Q4. DO YOU HAVE ANY CONCERNS WITH OR FEEDBACK ON THE PROPOSED PROCEDURES FOR INCORPORATION AND TRANSFER OF CELLS BEING CONTAINED IN THE RULES?
Q5. DO YOU HAVE ANY CONCERNS WITH OR FEEDBACK ON THE PROPOSED FILING AND CERTIFICATION REQUIREMENTS BEING CONTAINED IN THE RULES?
Q6. DO YOU AGREE THAT THE PROPOSALS PRESERVE THE SUBSTANTIVE LEGAL RIGHTS LIABILITIES AND PROTECTIONS APPLICABLE TO PCCS AND ICCS? PLEASE IDENTIFY ANY PROVISION THAT MAY HAVE AN UNINTENDED SUBSTANTIVE EFFECT?
Q7. DO YOU CONSIDER THAT THE USE OF CELL COMPANIES SHOULD BE RESTRICTED TO SPECIFIED BUSINESS ACTIVITIES OR SECTORS? IF SO WHAT ACTIVITIES OR SECTORS SHOULD BE PERMITTED OR RESTRICTED AND WHAT SHOULD BE THE BASIS FOR ANY RESTRICTIONS??
Subscribe